SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041604
Filing Date
2023-08-11
Accepted
2023-08-11 07:31:04
Documents
93
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-20230630.htm   iXBRL 10-Q 3960260
2 EX-10.1 itrm-ex10_1.htm EX-10.1 1071010
3 EX-31.1 itrm-ex31_1.htm EX-31.1 21628
4 EX-31.2 itrm-ex31_2.htm EX-31.2 21972
5 EX-32.1 itrm-ex32_1.htm EX-32.1 13024
6 EX-32.2 itrm-ex32_2.htm EX-32.2 13016
  Complete submission text file 0000950170-23-041604.txt   15517612

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20230630.xsd EX-101.SCH 92449
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20230630_pre.xml EX-101.PRE 523673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itrm-20230630_def.xml EX-101.DEF 368892
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20230630_lab.xml EX-101.LAB 654003
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itrm-20230630_cal.xml EX-101.CAL 59077
87 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20230630_htm.xml XML 2961072
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 231161531
SIC: 2834 Pharmaceutical Preparations